Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Monivent ABXSAT:MONI 19 Equity-to-Asset is 0.63 as of Jun. 2026, which is 5% below its 10-year median of 0.66. GuruFocus rates XSAT:MONI with a GF Score™ of 19/100 and a GF Value™ of kr0.05 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Monivent AB ranks worse than 50.47% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Monivent AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr15.75 Mil. Monivent AB's Total Assets for the quarter that ended in Jun. 2026 was kr24.88 Mil.
Therefore, Monivent AB's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.63.
The historical rank and industry rank for Monivent AB's Equity-to-Asset or its related term are showing as below:
XSAT:MONI'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0 Med: 0.66 Max: 0.92
Current: 0.63
During the past 9 years, the highest Equity to Asset Ratio of Monivent AB was 0.92. The lowest was 0.00. And the median was 0.66.
XSAT:MONI's Equity-to-Asset is ranked worse than 50.47% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs XSAT:MONI: 0.63
Monivent AB (XSAT:MONI) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Monivent AB Equity-to-Asset Related Terms
Monivent AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Monivent AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:MONI vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Monivent AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monivent AB Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Monivent AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Monivent AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Monivent AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monivent AB (XSAT:MONI) has a Equity-to-Asset of 0.63 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Monivent AB and its competitors. This is near median its historical median of 0.66. According to the industry distribution chart, Monivent AB ranks #430 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is Monivent AB's Equity-to-Asset too high?
Monivent AB's current Equity-to-Asset of 0.63 is near median its 10-year median of 0.66. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Monivent AB's value of 0.63 is 1.6% below this industry median. Based on the distribution chart, Monivent AB ranks #430 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Monivent AB has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monivent AB's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Monivent AB ranks #430 out of 852 companies for Equity-to-Asset. This places Monivent AB in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Monivent AB's value of 0.63 is 1.6% below this benchmark. While the company's 10-year median is 0.66 vs. the industry median of 0.64, Monivent AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Monivent AB's current Equity-to-Asset of 0.63 is 1.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Monivent AB and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monivent AB's current Equity-to-Asset is 0.63, which is near median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monivent AB stock overvalued right now?
Based on GuruFocus' analysis, Monivent AB (XSAT:MONI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.17 — trading 236% above its estimated fair value. The current Equity-to-Asset is 0.63, which is near median its 10-year median of 0.66 and 1.6% below the Medical Devices & Instruments industry median of 0.64. Monivent AB's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Monivent AB (XSAT:MONI), the current Equity-to-Asset is 0.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monivent AB (XSAT:MONI) Overvalued in 2026?
Based on GuruFocus' analysis, Monivent AB stock appears to be overvalued.
The current stock price of kr0.17 is trading 236% above its estimated GF Value™ of kr0.05.
GuruFocus considers Monivent AB to be Significantly Overvalued.
Key valuation signals for XSAT:MONI:
Equity-to-Asset: 0.63 (near median its 10-year median of 0.66)
GF Value™: kr0.05 vs. price of kr0.17 (236% above fair value)
Industry Position: 1.6% below the Medical Devices & Instruments median (#430 of 852)
No single metric tells the full story. See the XSAT:MONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.
19GF Score
Get the complete analysis for XSAT:MONI
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:MONI has been successfully added to your 
